once monthly glp-1 agonist Frontiers Ascletis ASC35 Clears FDA For

doi: 10.1016/j.phrs.2021.106033 36 KoppulaPZhuangLGanB

MATERIALS AND METHODS Animals Male Albino Wistar (200 g) rats, were used in all of the experiments approved by the Local Ethic Committee (at least 10 rats per each experimental group per each period), assessed by observers naive about the given treatment

doi:10.1016/j.bbagen.2012.09.008

While a preliminary cross-sectional analysis of baseline data in the trial has been published, this paper presents a much more comprehensive and in-depth analysis for this interventional study

And GLPs are not recommended in patient populations with: severe gastrointestinal diseases such as gastroparesis and inflammatory bowel disease